SEP 08, 2020 9:00 AM PDT

Advancing Toward Personalized Medicine in Lung Cancer: A Focus on Gene Rearrangement Testing

Speaker

Abstract
Date:  September 8, 2020
Time: 8:00am PDT,  11:00am EDT
 
Advances in genomics and molecular biomarker testing have led to tremendous improvements, ushering in a new era of personalized medicine especially in the oncology practice. Many of these biomarkers have been identified as receptor tyrosine kinases, shown to be involved in the signaling pathways associated with tumor growth and development. More interesting is that a subset of the genetic alterations observed in these biomarkers are gene rearrangements that result in constitutively activated tyrosine kinases, thus providing targets for therapies that could effectively inhibit the tyrosine kinase activity. Non-small cell lung cancer patients have benefited considerably, from these advances in targeted therapies, as there are already several therapeutics to which patients positive for specific gene rearrangements have shown remarkable response. Identifying such rearrangements is becoming part of the preliminary standard of care when diagnosing non-small cell lung cancer. Various diagnostic assays have been developed to provide such information. This webinar will review the available molecular methodologies for identifying gene rearrangements specifically focusing on ALK and ROS1 gene rearrangement testing in non-small cell lung cancer. Included in the review will be an overview of the technology, the current recommendations, common practices and challenges associated with these methodologies, to better understand the available options in order to choose the best course of action throughout the patient treatment cycle.
 
Learning Objectives
  • Review functionality of gene rearrangements
  • Overview of various methodologies for identifying gene rearrangements
  • Review of the guidelines, recommendations, common practices and difficulties associated with gene rearrangement testing
  • Considerations for the best course of action throughout the patient treatment cycle
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 28, 2022 6:45 AM PDT
JUN 28, 2022 6:45 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAY 24, 2022 11:00 AM PDT
MAY 24, 2022 11:00 AM PDT
Date: May 24, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 7:00pm (CEST) NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are c...
Loading Comments...
Show Resources